DEFR14A: BlackRock ESG Capital Allocation Term Trust Amends Proxy Statement Regarding Maryland Control Share Acquisition Act
Proxy Statement Amendment
BlackRock ESG Capital Allocation Term Trust amends its proxy statement to reflect a court decision impacting the applicability of the Maryland Control Share Acquisition Act to the Trust's upcoming shareholder meetings.
Summary
- BlackRock ESG Capital Allocation Term Trust filed an amendment to its proxy statement on May 20, 2024.
- This amendment relates to the annual meeting of shareholders scheduled for June 26, 2024.
- The amendment addresses a court decision regarding the applicability of the Maryland Control Share Acquisition Act to certain BlackRock-sponsored funds.
- A U.S. District Court ruled that elections by sixteen closed-end funds to be subject to the Maryland Control Share Acquisition Act violate Section 18(i) of the 1940 Act.
- The funds have appealed the district court's decision.
- As a result of the court's decision, the Maryland Control Share Acquisition Act will not apply to the Trust's 2024 and 2025 annual shareholder meetings.
- The amendment clarifies that information in the amendment supersedes any conflicting information in the original proxy statement filed on April 25, 2024.
Sentiment
Score: 6
Explanation: The document is a factual update regarding a legal matter and its impact on the proxy statement. The sentiment is neutral as it simply reflects a change in circumstances.
Future Outlook
The Maryland Control Share Acquisition Act will not apply to the Trusts 2024 and 2025 annual shareholder meetings.
Industry Context
This announcement highlights the complexities and potential legal challenges faced by closed-end funds regarding state control share acquisition acts, particularly in the context of shareholder voting rights and corporate governance.
Legal Proceedings
- The U.S. District Court for the Southern District of New York granted judgment in favor of a plaintiff's claim for rescission of resolutions by sixteen closed-end funds that opted in to elect to be subject to the Maryland Control Share Acquisition Act.
- The funds have appealed the district court's decision to the U.S. Court of Appeals for the Second Circuit.
Stakeholder Impact
- Shareholders should be aware that the Maryland Control Share Acquisition Act will not apply to the Trusts 2024 and 2025 annual shareholder meetings.
Key Dates
| Date | Description |
|---|---|
| December 5, 2023 | U.S. District Court granted judgment in favor of a plaintiff's claim for rescission of resolutions by sixteen closed-end funds that opted in to elect to be subject to the Maryland Control Share Acquisition Act. |
| April 25, 2024 | Original definitive proxy statement filed with the SEC. |
| May 20, 2024 | Amendment to proxy statement filed with the SEC. |
| June 26, 2024 | Annual meeting of shareholders to be held at 11:00 a.m. (Eastern time). |
Keywords
Proxy Statement, Amendment, BlackRock ESG Capital Allocation Term Trust, Maryland Control Share Acquisition Act, Shareholder Meeting, Closed-End Funds
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.